BACKGROUND Persistence of HIV in sanctuary sites despite antiretroviral therapy (ART) presents a barrier to HIV remission and may affect neurocognitive function. We assessed HIV persistence in cerebrospinal fluid (CSF) and associations with inflammation and neurocognitive performance during long-term ART.METHODS Participants enrolled in the AIDS Clinical Trials Group (ACTG) HIV Reservoirs Cohort Study (A5321) underwent concurrent lumbar puncture, phlebotomy, and neurocognitive assessment. Cell-associated HIV DNA and HIV RNA (CA-DNA, CA-RNA) were measured by quantitative PCR (qPCR). in peripheral blood mononuclear cells (PBMCs) and in cell pellets from CSF. In CSF supernatant and blood plasma, cell-free HIV RNA was quantified by qPCR with single copy sensitivity, and inflammatory biomarkers were measured by enzyme immunoassay.RESULTS Sixty-nine participants (97% male, median age 50 years, CD4 696 cells/mm3, plasma HIV RNA <100 copies/mL) were assessed after a median 8.6 years of ART. In CSF, cell-free RNA was detected in 4%, CA-RNA in 9%, and CA-DNA in 48% of participants (median level 2.1 copies/103 cells). Detection of cell-free CSF HIV RNA was associated with higher plasma HIV RNA (P = 0.007). CSF inflammatory biomarkers did not correlate with HIV persistence measures. Detection of CSF CA-DNA HIV was associated with worse neurocognitive outcomes including global deficit score (P = 0.005), even after adjusting for age and nadir CD4 count.CONCLUSION HIV-infected cells persist in CSF in almost half of individuals on long-term ART, and their detection is associated with poorer neurocognitive performance.FUNDING This observational study, AIDS Clinical Trials Group (ACTG) HIV Reservoirs Cohort Study (A5321), was supported by the National Institutes of Health (NIAID and NIMH).
Serena Spudich, Kevin R. Robertson, Ronald J. Bosch, Rajesh T. Gandhi, Joshua C. Cyktor, Hanna Mar, Bernard J. Macatangay, Christina M. Lalama, Charles Rinaldo, Ann C. Collier, Catherine Godfrey, Joseph J. Eron, Deborah McMahon, Jana L. Jacobs, Dianna Koontz, Evelyn Hogg, Alyssa Vecchio, John W. Mellors
Title and authors | Publication | Year |
---|---|---|
Inflammatory responses revealed through HIV infection of microglia-containing cerebral organoids
Narasipura SD, Zayas JP, Ash MK, Reyes AF, Shull T, Gambut S, Szczerkowski JL, McKee C, Schneider JR, Lorenzo-Redondo R, Al-Harthi L, Mamede JI |
Journal of Neuroinflammation | 2025 |
HIV, smoking, and the brain: a convergence of neurotoxicities
Orlinick BL, Farhadian SF |
AIDS Research and Therapy | 2025 |
HIV Cerebrospinal Fluid Escape: Interventions for the Management, Current Evidence and Future Perspectives
Kelly SH, Nightingale S, Gupta RK, Collier DA |
Tropical Medicine and Infectious Disease | 2025 |
Longitudinal CNS and systemic T-lymphocyte and monocyte activation before and after antiretroviral therapy beginning in primary HIV infection
Chan P, Li X, Li F, Emu B, Price RW, Spudich S |
Frontiers in Immunology | 2025 |
The cerebrospinal fluid virome in people with HIV: links to neuroinflammation and cognition
Trunfio M, Scutari R, Fox V, Vuaran E, Dastgheyb RM, Fini V, Granaglia A, Balbo F, Tortarolo D, Bonora S, Perno CF, Di Perri G, Alteri C, Calcagno A |
bioRxiv | 2025 |
Targeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce apoptosis of the latent HIV reservoir
Pascoe RD, Kim Y, Rhodes A, Ong J, Tumpach C, Gubser C, Chang JJ, McMahon JH, Lewin SR, Rasmussen TA |
Journal of Virology | 2025 |
A longitudinal analysis of neurocognitive profiles in South African women with HIV
Van der Watt A, Spies G, Seedat S |
AIDS care | 2025 |
Neuropathogenesis of acute HIV: mechanisms, biomarkers, and therapeutic approaches
Jia F(, Brew BJ |
Current Opinion in HIV and AIDS | 2025 |
Pharmacokinetic Approaches to Standardize Antiviral Exposure in Cerebrospinal Fluid
Avedissian SN, Mu Y, McCarthy C, Bosch RJ, Spudich S, Gandhi RT, McMahon DK, Eron JJ, Mellors JW, Liu J, Podany AT, Fletcher CV |
Pharmacotherapy | 2025 |
Rare HIV-1 infected T cell clones persist across cerebrospinal fluid and blood despite ART
Meng Wang, Jennifer Yoon, Hailey Reisert, Bibhuprasad Das, Jennifer Chiarella, Elias Halvas, John Mellors, Alina Pang, Lydia Barakat, Margaret Fikrig, Joshua Cyktor, Yuval Kluger, Serena Spudich, Michael Corley, Shelli Farhadian |
JCI Insight | 2024 |
Neurosymptomatic HIV-1 CSF escape is associated with replication in CNS CD4+ T cells and inflammation
Laura Kincer, Ameet Dravid, Mattia Trunfio, Andrea Calcagno, Shuntai Zhou, Riccardo Vercesi, Serena Spudich, Magnus Gisslen, Richard Price, Paola Cinque, Sarah Joseph |
Journal of Clinical Investigation | 2024 |
Microglial- neuronal crosstalk in chronic viral infection through mTOR, SPP1/OPN and inflammasome pathway signaling
Argandona Lopez C, Brown AM |
Frontiers in immunology | 2024 |
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy
Wagner TA, Tierney C, Huang S, Nichols S, Malee KM, Montañez NA, Coletti A, Spiegel HM, Krotje C, Bone F, Wilkins M, Abuogi L, Purswani M, Bearden A, Wiznia A, Agwu A, Chadwick EG, Richman D, Gandhi M, Mehta P, Macatangay B, Spector SA, Spudich S, Persaud D, Chahroudi A |
AIDS | 2024 |
The identification of intact HIV proviral DNA from human cerebrospinal fluid
Zhang Z, Reece MD, Roa S, Tyor W, Franklin DR, Letendre SL, Marconi VC, Anderson AM, Gavegnano C |
Neurotherapeutics | 2024 |
HIV-1 and methamphetamine co-treatment in primary human astrocytes: TAARgeting ER/UPR dysfunction.
Proulx JM, Park IW, Borgmann K |
NeuroImmune pharmacology and therapeutics | 2024 |
The Association Between Serum Mature and Precursor Brain-Derived Neurotrophic Factor and Neurocognitive Function in People With Human Immunodeficiency Virus: A Longitudinal Study
Michael HU, Rapulana AM, Smit T, Xulu N, Danaviah S, Ramlall S, Oosthuizen F |
Open Forum Infectious Diseases | 2024 |
Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection.
Hu Z, Cinque P, Dravid A, Hagberg L, Yilmaz A, Zetterberg H, Fuchs D, Gostner J, Blennow K, Spudich SS, Kincer L, Zhou S, Joseph SB, Swanstrom R, Price RW, Gisslén M |
PLoS pathogens | 2024 |
Brain microglia are a persistent HIV reservoir despite durable antiretroviral therapy
Yuyang Tang, Antoine Chaillon, Sara Gianella, Lilly Wong, Dajiang Li, Theresa Simermeyer, Magali Porrachia, Caroline Ignacio, Brendon Woodworth, Daniel Zhong, Jiayi Du, Eduardo Polina, Jenn Kirchherr, Brigitte Allard, Matthew Clohosey, Matt Moeser, Amy Sondgeroth, Gregory Whitehill, Vidisha Singh, Amir Dashti, Davey Smith, Joseph Eron, Katherine Bar, Ann Chahroudi, Sarah Joseph, Nancie Archin, David M. Margolis, Guochun Jiang |
Journal of Clinical Investigation | 2023 |
HIV infection of non-classical cells in the brain
Wahl A, Al-Harthi L |
Retrovirology | 2023 |
Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study
Wan Z, Tao R, Hui J, Liu X, Peng X, Guo Y, Zhu X, Huang Y, Zhu B |
Journal of Neuroinflammation | 2023 |
Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology
Joseph SB, Gianella S, Burdo TH, Cinque P, Gisslen M, Letendre S, Nath A, Morgello S, Ndhlovu LC, Spudich S |
The Journal of Infectious Diseases | 2023 |
Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques.
Byrnes SJ, Busman-Sahay K, Angelovich TA, Younger S, Taylor-Brill S, Nekorchuk M, Bondoc S, Dannay R, Terry M, Cochrane CR, Jenkins TA, Roche M, Deleage C, Bosinger SE, Paiardini M, Brew BJ, Estes JD, Churchill MJ |
PLoS pathogens | 2023 |
Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy
Gabuzda D, Yin J, Misra V, Chettimada S, Gelman BB |
Viruses | 2023 |
Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus
Letendre SL, Chen H, McKhann A, Roa J, Vecchio A, Daar ES, Berzins B, Hunt PW, Marra CM, Campbell TB, Coombs RW, Ma Q, Swaminathan S, Macatangay BJ, Morse GD, Miller T, Rusin D, Greninger AL, Ha B, Alston-Smith B, Robertson K, Paul R, Spudich S |
Clinical Infectious Diseases | 2023 |
CSF Inflammation Markers Associated with Asymptomatic Viral Escape in Cerebrospinal Fluid of HIV-Positive Individuals on Antiretroviral Therapy
Guha D, Misra V, Yin J, Gabuzda D |
Viruses | 2023 |
Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus
Yucha R, Litchford ML, Fish CS, Yaffe ZA, Richardson BA, Maleche-Obimbo E, John-Stewart G, Wamalwa D, Overbaugh J, Lehman DA |
Viruses | 2023 |
Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management.
Ellis RJ, Marquine MJ, Kaul M, Fields JA, Schlachetzki JCM |
Nature reviews. Neurology | 2023 |
HIV viral transcription and immune perturbations in the CNS of people with HIV despite ART
Shelli F. Farhadian, Ofir Lindenbaum, Jun Zhao, Michael J Corley, Yunju Im, Hannah L Walsh, Alyssa Vecchio, Rolando Garcia-Milian, Jennifer Chiarella, Michelle Chintanaphol, Rachela Calvi, Guilin Wang, Lishomwa c. Ndhlovu, Jennifer Yoon, Diane G. Trotta, Shuangge Ma, Yuval Kluger, Serena Spudich |
JCI Insight | 2022 |
Intact HIV proviruses persist in the central nervous system despite viral suppression with antiretroviral therapy
Catherine Cochrane, Thomas Angelovich, Aleks Guanizo, Gemma Trollope, Lachlan Senior, Emma Wanicek, Janna Eddine, Matthew Gartner, Emily Waring, Jacob Estes, Bruce Brew, Sharon Lewin, Michael Roche, Melissa Churchill |
Annals of Neurology | 2022 |
Senotherapeutics in Cancer and HIV
L Sánchez-Díaz, A Espinosa-Sánchez, J Blanco, A Carnero |
Cells | 2022 |
HIV Compartmentalization in the CNS and Its Impact in Treatment Outcomes and Cure Strategies
P Chan, S Spudich |
Current HIV/AIDS Reports | 2022 |
HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy
Jennifer Zerbato, Anchalee Avihingsanon, Kasha Singh, Wei Zhao, Claire Deleage, Elias Rosen, Mackenzie Cottrell, Ajantha Rhodes, Ashanti Dantanarayana, Carolin Tumpach, Surekha Tennakoon, Megan Crane, David Price, Sabine Braat, Hugh Mason, Michael Roche, Angela Kashuba, Peter Revill, Jennifer Audsley, Sharon Lewin |
EBioMedicine | 2022 |
A Non-Canonical Role for IRE1α Links ER and Mitochondria as Key Regulators of Astrocyte Dysfunction: Implications in Methamphetamine use and HIV-Associated Neurocognitive Disorders
Proulx J, Stacy S, Park IW, Borgmann K |
Frontiers in neuroscience | 2022 |
Cytomegalovirus: 40 years and still the major viral cofactor in HIV infection
Rinaldo CR |
AIDS | 2022 |
Methamphetamine induces transcriptional changes in cultured HIV-infected mature monocytes that may contribute to HIV neuropathogenesis
Chilunda V, Weiselberg J, Martinez-Meza S, Mhamilawa LE, Cheney L, Berman JW |
Frontiers in immunology | 2022 |
No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART.
Ward AR, Thomas AS, Stevenson EM, Huang SH, Keating SM, Gandhi RT, McMahon DK, Bosch RJ, Macatangay BJ, Cyktor JC, Eron JJ, Mellors JW, Jones RB |
AIDS | 2022 |
Effects of Morphine on Gp120-induced Neuroinflammation Under Immunocompetent Vs. Immunodeficient Conditions.
Canonico D, Casale S, Look T, Cao L |
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology | 2022 |
Lessons for Understanding Central Nervous System HIV Reservoirs from the Last Gift Program.
Riggs PK, Chaillon A, Jiang G, Letendre SL, Tang Y, Taylor J, Kaytes A, Smith DM, Dubé K, Gianella S |
Current HIV/AIDS Reports | 2022 |
Molecular neuroimaging of inflammation in HIV.
Alagaratnam J, Winston A |
Clinical & Experimental Immunology | 2022 |
A Rationale and Approach to the Development of Specific Treatments for HIV Associated Neurocognitive Impairment
Scanlan A, Zhang Z, Koneru R, Reece M, Gavegnano C, Anderson AM, Tyor W |
Microorganisms | 2022 |
Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections.
Reece MD, Song C, Hancock SC, Pereira Ribeiro S, Kulpa DA, Gavegnano C |
Frontiers in immunology | 2022 |
Shock and kill within the CNS: A promising HIV eradication approach?
Nühn MM, Gumbs SB, Buchholtz NV, Jannink LM, Gharu L, de Witte LD, Wensing AM, Lewin SR, Nijhuis M, Symons J |
Journal of leukocyte biology | 2022 |
Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury
Suzuki K, Zaunders J, Gates TM, Levert A, Butterly S, Liu Z, Ishida T, Palmer S, Rae CD, Jugé L, Cysique LA, Brew BJ |
Proceedings of the National Academy of Sciences | 2022 |
Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy
M Scherpenisse, NA Kootstra, M Bakker, B Berkhout, AO Pasternak, TE Smithgall |
mBio | 2021 |
Targeting Macrophage Dysregulation for Viral Infections: Novel Targets for Immunomodulators
MD Reece, RR Taylor, C Song, C Gavegnano |
Frontiers in immunology | 2021 |
Co-receptor signaling in the pathogenesis of neuroHIV
EA Nickoloff-Bybel, L Festa, O Meucci, PJ Gaskill |
Retrovirology | 2021 |
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
SG Deeks, N Archin, P Cannon, S Collins, RB Jones, MA de Jong, O Lambotte, R Lamplough, T Ndungu, J Sugarman, CT Tiemessen, L Vandekerckhove, SR Lewin, S Deeks, S Lewin, M de Jong, Z Ndhlovu, N Chomont, Z Brumme, K Deng, L Jasenosky, R Jefferys, A Orta-Resendiz, F Mardarelli, M Nijhuis, K Bar, B Howell, A Schneider, G Turk, R Nabatanzi, J Blankson, JV Garcia, M Paiardini, J van Lunzen, C Antoniadi, FH Côrtes, S Valente, OS Søgaard, RS Diaz, M Ott, R Dunham, S Schwarze, SP Patrigeon, J Nabukenya, M Caskey, B Mothe, FS Wang, S Fidler, D SenGupta, S Dressler, M Matoga, HP Kiem, P Tebas, C Kityo, B Dropulic, M Louella, KT Das, D Persaud, A Chahroudi, K Luzuriaga, T Puthanakit, J Safrit, G Masheto, K Dubé, J Power, J Salzwedel, U Likhitwonnawut, J Taylor, OL Nuh, K Dong, EN Kankaka |
Nature Medicine | 2021 |
T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy
G Lustig, S Cele, F Karim, A Derache, A Ngoepe, K Khan, BI Gosnell, MY Moosa, N Ntshuba, S Marais, PM Jeena, K Govender, J Adamson, H Kløverpris, RK Gupta, R Harrichandparsad, VB Patel, A Sigal, R Swanstrom |
PLoS pathogens | 2021 |
Cerebrospinal fluid CXCL10 is associated with the presence of low level CSF HIV during suppressive antiretroviral therapy
AM Anderson, S Kundu, B Tang, F Vaida, O Okwuegbuna, D McClernon, M Cherner, R Deutsch, D Cookson, M Crescini, I Grant, H Zetterberg, K Blennow, M Gisslen, RJ Ellis, SL Letendre |
Journal of Neuroimmunology | 2021 |
A streamlined clinical metagenomic sequencing protocol for rapid pathogen identification
X Jia, L Hu, M Wu, Y Ling, W Wang, H Lu, Z Yuan, Z Yi, X Zhang |
Scientific Reports | 2021 |
Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression
M Gisslen, SM Keating, S Spudich, V Arechiga, S Stephenson, H Zetterberg, CD Germanio, K Blennow, D Fuchs, L Hagberg, PJ Norris, J Peterson, BL Shacklett, CT Yiannoutsos, RW Price, A Calcagno |
PloS one | 2021 |
Preliminary In Vivo Evidence of Reduced Synaptic Density in Human Immunodeficiency Virus (HIV) Despite Antiretroviral Therapy
JJ Weiss, R Calvi, M Naganawa, T Toyonaga, SF Farhadian, M Chintanaphol, J Chiarella, MQ Zheng, J Ropchan, Y Huang, RH Pietrzak, RE Carson, S Spudich |
Clinical Infectious Diseases | 2021 |
Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection
G Mak, JJ Zaunders, M Bailey, N Seddiki, G Rogers, L Leong, TG Phan, AD Kelleher, KK Koelsch, MA Boyd, M Danta |
Frontiers in immunology | 2021 |
Intramuscular and subcutaneous administration of antiretroviral drugs, compared with oral, enhances delivery to lymphoid tissues in BALB/c mice
SR Dyavar, S Kumar, N Gautam, AT Podany, LC Winchester, JA Weinhold, TM Mykris, P Nallasamy, Y Alnouti, CV Fletcher |
Journal of Antimicrobial Chemotherapy | 2021 |
Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage
AR Denton, CF Mactutus, AU Lateef, SB Harrod, RM Booze |
Journal of Neurovirology | 2021 |
Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study
AM Anderson, B Tang, F Vaida, D Mcclernon, R Deutsch, M Cherner, D Cookson, M Crescini, I Grant, RJ Ellis, SL Letendre |
Journal of acquired immune deficiency syndromes (1999) | 2021 |
Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era
AM Anderson, Q Ma, SL Letendre, J Iudicello |
Current HIV/AIDS Reports | 2021 |
Central Nervous System Effects of COVID-19 in People with HIV Infection
MJ Peluso, J Hellmuth, FC Chow |
Current HIV/AIDS Reports | 2021 |
Immunotherapeutics to Treat HIV in the Central Nervous System
A Kapoor, CS Tan |
Current HIV/AIDS Reports | 2020 |
The Brain Retains: Nonhuman Primate Models for Pediatric HIV-1 in the CNS
V Obregon-Perko, K Bricker, A Chahroudi |
Current HIV/AIDS Reports | 2020 |
Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infection
FJ Mahmud, Y Du, E Greif, T Boucher, RF Dannals, WB Mathews, MG Pomper, P Sysa-Shah, KA Pate, C Lyons, B Carlson, M Chacona, AM Brown |
Journal of Neuroinflammation | 2020 |
Interactions of Monocytes, HIV, and ART Identified by an Innovative scRNAseq Pipeline: Pathways to Reservoirs and HIV-Associated Comorbidities
R León-Rivera, B Morsey, M Niu, HS Fox, JW Berman, BD Walker, SP Goff |
mBio | 2020 |
Pharmacologic approaches to HIV-associated neurocognitive disorders
SN Avedissian, SR Dyavar, HS Fox, CV Fletcher |
Current Opinion in Pharmacology | 2020 |
New Potential Axes of HIV Neuropathogenesis with Relevance to Biomarkers and Treatment
Thomas A Angelovich, Melissa J Churchill, Edwina J Wright, Bruce J Brew |
Current Topics in Behavioral Neurosciences | 2020 |
The far-reaching HAND of cART: cART effects on astrocytes
H Gonzalez, A Podany, L Al-Harthi, J Wallace |
Journal of Neuroimmune Pharmacology | 2020 |
HIV Nef and Antiretroviral Therapy Have an Inhibitory Effect on Autophagy in Human Astrocytes that May Contribute to HIV-Associated Neurocognitive Disorders
L Cheney, H Guzik, FP Macaluso, F Macian, AM Cuervo, JW Berman |
Cells | 2020 |
Chronic inflammation mediates brain injury in HIV infection: relevance for cure strategies
JC McArthur, TP Johnson |
Current Opinion in Neurology | 2020 |
Effects of HIV gp120 on Neuroinflammation in Immunodeficient vs. Immunocompetent States
TJ Arabatzis, AA Wakley, VD McLane, D Canonico, L Cao |
Journal of Neuroimmune Pharmacology | 2020 |
Machine learning analysis reveals novel neuroimaging and clinical signatures of frailty in HIV
RH Paul, KS Cho, PM Luckett, JF Strain, AC Belden, JD Bolzenius, J Navid, PM Garcia-Egan, SA Cooley, JK Wisch, AH Boerwinkle, D Tomov, A Obosi, JA Mannarino, BM Ances |
Journal of acquired immune deficiency syndromes (1999) | 2020 |
Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system
D Gabuzda, JC McArthur, SL Letendre |
AIDS | 2020 |
Comparison of [11C]-PBR28 binding between persons living with HIV and HIV uninfected individuals
AH Boerwinkle, JF Strain, T Burdo, J Doyle, J Christensen, Y Su, JK Wisch, SA Cooley, F Vaida, MD Smith, H Jafri, RH Paul, TL Benzinger, BM Ances |
Journal of acquired immune deficiency syndromes (1999) | 2020 |
Is successful HIV therapy a Pyrrhic victory for the brain?
David Clifford |
Journal of Clinical Investigation | 2019 |
Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
JL Jacobs, EK Halvas, MA Tosiano, JW Mellors |
Frontiers in microbiology | 2019 |
Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults
SM Matt, PJ Gaskill |
Brain Research | 2019 |
Markers of CNS Injury in Adults Living With HIV With CSF HIV Not Detected vs Detected <20 Copies/mL
SF Farhadian, H Mistry, T Kirchwey, J Chiarella, R Calvi, M Chintanaphol, P Patel, ML Landry, K Robertson, SS Spudich |
Open Forum Infectious Diseases | 2019 |
Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV
JJ Kim-Chang, K Donovan, MS Loop, S Hong, B Fischer, G Venturi, PA Garvie, J Kohn, HJ Rendina, SP Woods, MM Goodenow, SL Nichols, JW Sleasman |
AIDS | 2019 |